Number of Patients per Cohort and Sample Size Considerations Using Dose Escalation with Overdose Control
about
Dose finding with drug combinations in cancer phase I clinical trials using conditional escalation with overdose control.Escalation with overdose control using time to toxicity for cancer phase I clinical trials.Sample size formulae for the Bayesian continual reassessment method.A Bayesian adaptive design for estimating the maximum tolerated dose curve using drug combinations in cancer phase I clinical trials.
P2860
Number of Patients per Cohort and Sample Size Considerations Using Dose Escalation with Overdose Control
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2012
@uk
name
Number of Patients per Cohort ...... calation with Overdose Control
@en
Number of Patients per Cohort ...... calation with Overdose Control
@nl
type
label
Number of Patients per Cohort ...... calation with Overdose Control
@en
Number of Patients per Cohort ...... calation with Overdose Control
@nl
prefLabel
Number of Patients per Cohort ...... calation with Overdose Control
@en
Number of Patients per Cohort ...... calation with Overdose Control
@nl
P2860
P356
P1476
Number of Patients per Cohort ...... calation with Overdose Control
@en
P2093
André Rogatko
Mourad Tighiouart
P2860
P356
10.1155/2012/692725
P577
2012-01-01T00:00:00Z